ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 733795 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 733795; 2) Community: the network communities that were significantly associated with the response to NSC 733795; 3) Molecule: the relationships between components within communities and NSC 733795; 4) MDR: the compounds that were significantly associated with the NSC 733795.

NSC Compound Enrichment Correlation
NSC 619961 Primaquine diphosphate 0.0342636096654276 0.20499208
NSC 622124 Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) 0.0342636096654276 0.028170272
NSC 632855 9-Chloro-2-methylellipticinium acetate, hydrate 0.0342636096654276 -0.30240045
NSC 633273 ANTINEOPLASTIC-633273 0.0342636096654276 0.13717873
NSC 637127 Null 0.0342636096654276 0.120907
NSC 637130 Null 0.0342636096654276 0.18628732
NSC 639516 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(3,4- dimethoxyphenyl)methylene]-, hydrochloride 0.0342636096654276 0.26365586
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0342636096654276 0.29573467
NSC 645389 Null 0.0342636096654276 0.36853682
NSC 645809 Null 0.0342636096654276 0.18451796
Total:129  Current:100    [First] [Prev] [Next] [Last]